###begin article-title 0
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 1
###begin p 2
###xml 606 642 606 642 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oupjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
###end p 2
###begin p 3
###xml 363 368 363 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 434 451 434 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 595 602 595 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 630 633 630 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 673 676 673 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 813 818 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 1152 1159 1152 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
###xml 405 420 <span type="species:ncbi:10090">transgenic mice</span>
###xml 694 709 <span type="species:ncbi:10090">transgenic mice</span>
###xml 734 739 <span type="species:ncbi:10090">mouse</span>
###xml 926 941 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
RNA interference (RNAi)-mediated gene knockdown is a potent approach for studying gene function. We have previously reported a plasmid-based, tamoxifen-inducible gene knockdown system in cultured cells using a combined RNAi and Cre-LoxP system. Here, we validate this system in mouse and show that it can be used to suppress the expression of an endogenous gene (Fgfr2) with high efficiency. We show that transgenic mice carrying the U6-ploxPneo-Fgfr2 RNAi construct are normal, displaying Fgfr2 transcripts equivalent to those of wild-type controls, indicating that the U6 promoter is inactive in vivo due to the presence of the neo in the promoter. After excision of the neo by crossing with transgenic mice that express Cre in the mouse germline, the U6 promoter is activated, leading to over 95% reduction of Fgfr2 transcripts, and consequently, embryonic lethality. On the other hand, activation of the U6 promoter using transgenic mice that express Cre in the progress zone of the limb results in live mice with malformation of digits of both the forelimbs and hindlimbs. This method provides a fast, yet efficient way to decipher gene functions in vivo in a tissue-specific manner.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 547 548 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
RNA interference (RNAi) is widely used to target and degrade specific mRNA (1). Small interfering RNA or short hairpin RNA (shRNA)-producing vectors can be transfected in cultured cells, allowing mRNA down-regulation within 24-72 h (1-5). Plasmids can be stably integrated into host genome and provide several advantages compared with transfected siRNA oligos (1-5). In order to provide a controllable RNAi, several studies have developed inducible regulation of RNAi in mammalian cells using either tetracycline or ecdysone-responsive systems (6-9).
###end p 5
###begin p 6
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 199 202 199 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 288 291 288 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 318 326 318 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ploxPneo</italic>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 971 987 971 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-RNAi</italic>
###xml 1180 1187 1180 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 652 657 <span type="species:ncbi:10090">mouse</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 805 810 <span type="species:ncbi:10090">mouse</span>
###xml 1004 1009 <span type="species:ncbi:10090">mouse</span>
###xml 1081 1096 <span type="species:ncbi:10090">transgenic mice</span>
Recently, we have reported a tamoxifen-inducible gene knockdown system in cultured cells using a combination of the RNAi and the Cre-LoxP system (3). In this method, we inserted a neomycin cassette (neo) (10) into the RNA polymerase III (U6) promoter to disrupt its activity. Because the neo is flanked by loxP sites (ploxPneo), it can be excised upon the Cre-mediated recombination, thus restoring the activity of the U6 promoter (3). Using a tamoxifen-inducible Cre (11), we have demonstrated that this process indeed works with high efficiency in the suppression of two endogenous genes, fibroblast growth factor receptor 2 (Fgfr2) and Survivin, in mouse embryonic stem (ES) cells (3). The Cre-LoxP system has been widely utilized for conditional gene knockout in mice (12-14), and numerous transgenic mouse strains expressing Cre at specific tissues/organs have been developed to achieve spatial and temporal control of gene expression (15). We postulate that if our U6-ploxPneo-RNAi vector works in mouse, it will eventually allow the utilization of a large collection of Cre transgenic mice and significantly enhance our ability to use RNAi system to decipher gene function in vivo.
###end p 6
###begin p 7
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1235 1252 1235 1244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;III/&#916;III</sup>
###xml 1230 1252 1230 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2<sup>&#916;III/&#916;III</sup></italic>
###xml 1329 1331 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 1409 1426 1401 1410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;III/&#916;III</sup>
###xml 1404 1426 1396 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2<sup>&#916;III/&#916;III</sup></italic>
###xml 1520 1522 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 555 561 <span type="species:ncbi:9606">humans</span>
###xml 729 737 <span type="species:ncbi:9606">patients</span>
###xml 897 902 <span type="species:ncbi:10090">mouse</span>
FGFR2 is one of the four high affinity FGF receptors that mediate the signaling of, at least, 22 FGF ligands (16,17). Full-length form of FGFR2 contains a hydrophobic leader sequence, three immunoglobulin (Ig)-like domains, an acidic box, a transmembrane domain and a divided tyrosine kinase domain. Many isoforms can be generated through alternative splicing and internal poly-adenylation. For example, alterations in exons 7-9 that encode the IgIII yield b (FGFR2b) and c (FGFR2c) isoforms (18,19). It has been shown that missense mutations of FGFR2 in humans result in at least seven distinct types of craniosynostosis syndromes, primarily affecting bones formed through intramembraneous ossification [reviewed in (17)]. Some patients also display limb abnormalities at birth, such as short fingers, broad thumbs, bigger toes and/or soft-tissue syndactyly [reviewed in (20)]. Gene targeting in mouse revealed that Fgfr2 plays important roles in embryonic development and organogenesis. It has been demonstrated that Fgfr2-null embryos die a few hours after implantation owing to abnormalities during the implantation process and malformation of the egg cylinder (21). Mutant embryos homozygous for Fgfr2-IgIII domain deletion (Fgfr2DeltaIII/DeltaIII) die at embryonic day (E) 10.5-11.5 owing to failure of placenta formation (22). After rescue of placenta defects with wild-type tetraploid cells, the Fgfr2DeltaIII/DeltaIII embryos survive up to birth; however, they display abnormalities in multiple organs/tissues (23).
###end p 7
###begin p 8
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
###xml 276 291 <span type="species:ncbi:10090">transgenic mice</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
Considering embryonic lethality associated with the loss of function mutations and the potential critical roles of FGFR2 in postnatal development (17), we decided to knockdown this gene in mouse to test the efficiency of our Cre-mediated RNAi strategy. By using two different transgenic mice that express the Cre in the germline and the progress zone of the limb, respectively, we have generated mouse models with dramatically reduced expression of Fgfr2 that can be used to study functions of this gene in a tissue-specific manner.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
Generation of transgenic mice
###end title 10
###begin p 11
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pBS/U6-ploxPneo-Fgfr2</italic>
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 683 686 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
pBS/U6-ploxPneo-Fgfr2 vector used in this study was described previously (3). The vector was digested by KpnI and AflIII restriction enzymes and purified from agarose gel after electrophoretic migration using the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA). The fragment (2745 bp) was resuspended in Tris (1 mM)-EDTA (0.1 mM) buffer and adjusted to a final concentration of 2 ng/mul and injected into oocytes isolated from FVB/N mice through pronuclear injection. Offspring from the injection were genotyped using PCR with the following pair of primers (5'-CGAAGTTATCTAGAGTCGAC-3' and 5'-AAACAAGGCTTTTCTCCAAGG-3') that amplifies 102 bp from the U6 promoter and the connecting neo gene. PCR-positive mice were crossed with wild-type FVB/N mice to obtain germline transmission. Three chimeric mice passed the transgene through germline.
###end p 11
###begin title 12
###xml 23 33 23 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2-RNAi</italic>
Functional analysis of Fgfr2-RNAi transgene
###end title 12
###begin p 13
###xml 18 40 18 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2-RNAi</italic>
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ap2-Cre</italic>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 142 152 142 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2-RNAi</italic>
###xml 168 176 168 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 186 193 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ap2-Cre</italic>
###xml 346 372 346 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre;U6-ploxPneo-Fgfr2</italic>
###xml 377 402 377 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ap2-Cre;U6-ploxPneo-Fgfr2</italic>
###xml 657 665 657 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ploxPneo</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 100 115 <span type="species:ncbi:10090">transgenic mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
Mice carrying the U6-ploxPneo-Fgfr2-RNAi transgene were crossed with EIIa-Cre (24) and Ap2-Cre (25) transgenic mice to assess efficiencies of Fgfr2-RNAi transgene. The EIIa-Cre mice and Ap2-Cre mice were genotyped using the following pair of primers (Cre-1: 5'-CCT GTT TTG CAC GTT CAC CG-3' and Cre-3: 5'-ATG CTT CTG TCC GTT TGC CG-3'). Pregnant EIIa-Cre;U6-ploxPneo-Fgfr2 and Ap2-Cre;U6-ploxPneo-Fgfr2 mice were killed at different stages of pregnancy to check embryonic development. Cre mediated recombination was verified by using the following pair of primers (5'-GACGCCGCCATCTCTAGG-3' and 5'-AGGCTTTTCTCCAAGGGATATT-3'). This pair of primers flanks the ploxPneo in the U6 promoter and amplifies 278 bp after Cre-mediated recombination. Animals were handled in accordance with guidelines of the NIDDK Animal Care and Users Committee.
###end p 13
###begin title 14
Whole-mount skeletal preparation
###end title 14
###begin p 15
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
Animals were euthanized by asphyxiation with CO2. After removing the skin, carcasses were eviscerated, fixed in 95% ethanol, stained with Alizarin red S and alcian blue, cleared by KOH treatment, then stored in glycerol as described previously (26).
###end p 15
###begin title 16
PCR, RT-PCR and real-time PCR
###end title 16
###begin p 17
###xml 326 328 316 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 732 735 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
RT-PCR was performed on total RNA extracted from embryos using RNA STAT-60 (Tel-Test, Inc., Friendswood, TX) and reverse-transcription was performed according to Ambion's instructions using 'Cells-to-cDNAtrade mark II kit (Catalog nos 1722, 1723)'. Two micrograms of RNA were used for cDNA synthesis using 0.5 mug of oligo(dT)18 primer, 1 mul of RNase inhibitor, 1 mul of M-MLV reverse transcriptase and 2 mul of 10x RT buffer (Ambion) in a final volume of 20 mul. The reaction was carried out for 45 min at 42degreesC and for 10 min at 95degreesC and then cooled to 4degreesC. An aliquot of 1 mul of each RT reaction product was amplified to a 24 mul-volume PCR premix, containing 1 pmol of each primer, 2.5 mM dNTP mix and 1 U of Taq polymerase. PCR was carried out in a PCR thermal cycler (Gene Amp PCR Systems 9700). The samples were heated to 94degreesC for 2 min, and run through 22-31 cycles (95degreesC for 10 s, 60degreesC for 20 s and 72degreesC for 30 s) to monitor linearity of the amplification. The PCR was kept in 72degreesC for 10 min and then stopped at 4degreesC.
###end p 17
###begin p 18
RT-PCR was performed using the following primers: Fgfr1-F: 5'-TTCTGGGCTGTGCTGGTCAC-3' and Fgfr1-R: 5'-GCGAACCTTGTAGCCTCCAA-3'; Fgfr2-F: 5'-AAGGTTTACAGCGATGCCCA-3' and Fgfr2-R: 5'-ACCACCATGCAGGCGATTAA-3'; Fgfr3-F: 5'-CTAGTGTTCTGCGTGGCGGT-3' and Fgfr3-R: 5'-TTCTTATCCATTCGCTCCGG-3'; Fgfr4-F: 5'-CTGTTGAGCATCTTTCAGGG-3' and Fgfr4-R: 5'-CGTGGAAGGCCTGTCCATCC-3'.
###end p 18
###begin p 19
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr1</italic>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr3</italic>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr4</italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
We measured relative gene expression by real-time RT-PCR as suggested by the manufacturer (ABI PRISM 7500 Realtime System; Applied Biosystems) using the above primers for Fgfr1, Fgfr3 and Fgfr4. Fgfr2 primers were described as Fgfr2-Up: 5'-TGCCCTACCTCAAGGTTCTG-3'; and Fgfr2-Down: TAGAATTACCCGCCAAGCAC-3'.
###end p 19
###begin p 20
The following pair of primers for beta-actin was used as control for both RT-PCR and real-time PCR: beta-actin-Up: 5'-TGCGTGACATCAAAGAGAAG-3'; beta-actin-Down: 5'-GATGCCACAGGATTCCATA-3'.
###end p 20
###begin p 21
The following primers were used for genomic real-time PCR: Neo-U: 5'-AGAGGCTATTCGGCTATGACTG-3'; Neo-D: 5'-GTGGCCAGCCACGATAGC-3'; Fgfr1-U: 5'-CCCCATCCCATTTCCTTACCT-3'; and Fgfr1-D: 5'-TTCTGGT GTGTCTGAAAACAGCT-3'.
###end p 21
###begin p 22
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
For amplification of neo gene and neo deletion by genomic PCR, following pairs of primer were used: Neo-1: 5'-AGAGGCTATTCGGCTATGACTG-3'; Neo-2: 5'-TTCGTCCAGATCATCCTGATC-3'; Del-1: 5'-CGCACAGACTTGTGGGAGAA-3'; and Del-2: 5'-CACAATTACTTTACAGTTAG-3'. Fifty nanograms of DNA was used in the reaction.
###end p 22
###begin title 23
Northern blotting
###end title 23
###begin p 24
###xml 164 165 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 336 338 331 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 409 414 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
For analysis of the shRNA expression, 20 mug of total RNAs were resolved in a 15% (wt/vol) polyacrylamide-8 M urea gel, transferred by electroblotting onto Nytran-N+ membrane (Schleicher & Schuell, Keene N.H.) and was cross linked by using the auto-crosslink function of a Stratlinker. The membrane was hybridized overnight to a [gamma-32P]labeled DNA probe corresponding to the 21mer antisense strand of the Fgfr2 shRNA (GGCCTCAGCGTTCCTGAGCGA). The hybridization (Sigma, Hybridization buffer, PerfectHybtrade mark Plus) and wash steps were carried out at 37degreesC. The membrane was then exposed on a Kodak film for overnight before developing the image.
###end p 24
###begin title 25
RESULTS
###end title 25
###begin title 26
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2</italic>
Expression of U6-Fgfr2 results in embryonic lethality
###end title 26
###begin p 27
###xml 42 55 42 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2 in vivo</italic>
###xml 95 112 95 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 114 123 114 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 233 250 233 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 344 347 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 421 429 421 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 578 586 578 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 634 655 634 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EII&#945;-Cre</italic>
###xml 663 670 659 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 688 705 684 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 710 718 706 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 817 826 813 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 955 970 951 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1C and D</xref>
###xml 1050 1071 1046 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EII&#945;-Cre</italic>
###xml 1200 1208 1192 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2</italic>
###xml 1351 1373 1343 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2 mice</italic>
###xml 1388 1396 1380 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 1498 1519 1490 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EII&#945;-Cre</italic>
###xml 1563 1570 1551 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1588 1605 1576 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 1610 1618 1598 1606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 1720 1735 1696 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1D and E</xref>
###xml 1804 1812 1780 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 1816 1833 1792 1809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 70 85 <span type="species:ncbi:10090">transgenic mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 287 302 <span type="species:ncbi:10090">transgenic mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 430 445 <span type="species:ncbi:10090">transgenic mice</span>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 587 602 <span type="species:ncbi:10090">transgenic mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
###xml 1313 1317 <span type="species:ncbi:10090">mice</span>
###xml 1369 1373 <span type="species:ncbi:10090">mice</span>
###xml 1397 1401 <span type="species:ncbi:10090">mice</span>
###xml 1619 1623 <span type="species:ncbi:10090">mice</span>
To study the potential effects of RNAi of Fgfr2 in vivo, we generated transgenic mice carrying U6-ploxPneo-Fgfr2 (Figure 1A) through pronuclear injection. After breeding with FVB/N mice, three offspring from the injection passed the U6-ploxPneo-Fgfr2 transgene through germline. All the transgenic mice were normal owing to the presence of the neo, which blocks U6 promoter activity (3). Next, we crossed these mice with EIIa-Cre transgenic mice that express Cre in germ cells of the mouse (24). After screening 81 mice generated from breeding of one founder line (Line A) with EIIa-Cre transgenic mice, we obtained two live bigenic (U6-Fgfr2;EIIalpha-Cre) mice (Table 1, crosses between U6-ploxPneo-Fgfr2 and EIIa-Cre mice). Both mice appeared unhealthy at birth and were much smaller than their littermate control (Figure 1B) with a body weight of about two-third of their littermates at postnatal day 19 (P19). Both mice also displayed abnormal limbs (Figure 1C and D). Screening of 40 offspring from other two founder lines failed to obtain live U6-Fgfr2;EIIalpha-Cre mice at birth, suggesting that they were also embryonic lethal. Altogether, these observations suggested that the expression of U6-Fgfr2 RNAi might result in severe developmental defects, leading to embryonic lethality of majority of mutant mice. To confirm this, we crossed the U6-ploxPneo-Fgfr2 mice (Line A) with EIIa-Cre mice and dissected females at days 11.5 through 13.5 during their pregnancy. Our data indicated that U6-Fgfr2;EIIalpha-Cre embryos were present at a Mendelian ratio (Table 1, crosses between U6-ploxPneo-Fgfr2 and EIIa-Cre mice). However, approximately60% (8/14) of them were developmentally abnormal or partially resorbed (Figure 1D and E), while no obvious differences were found among control (wild type, EIIa-Cre or U6-ploxPneo-Fgfr2) embryos in the same litters.
###end p 27
###begin p 28
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ploxPneo</italic>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 306 311 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 364 371 364 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 496 513 496 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 594 597 594 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 678 687 678 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 744 747 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 781 798 769 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 846 855 834 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 882 885 870 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 964 967 952 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 969 978 957 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1025 1028 1013 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 1083 1091 1071 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ploxPneo</italic>
###xml 1172 1189 1160 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 1258 1267 1246 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1338 1355 1326 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 1371 1388 1359 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 1611 1628 1599 1616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 1655 1672 1643 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 1682 1691 1670 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 1713 1720 1701 1708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1755 1758 1743 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 431 446 <span type="species:ncbi:10090">transgenic mice</span>
###xml 622 637 <span type="species:ncbi:10090">transgenic mice</span>
Our previous study performed in ES cells indicated that Cre-mediated deletion of the ploxPneo restored the original distance between the distal sequence element and the proximal sequence element in the U6 promoter. It allowed the expression of Fgfr2 RNAi, and, consequently, led to a markedly reduction of Fgfr2 transcripts (3). To determine whether this occurred in vivo, we performed the following three experiments using Line A transgenic mice: we first determined the number of copies of the U6-ploxPneo-Fgfr2 transgene by real-time PCR. Our analysis using a pair of primers located in the neo gene indicated that the transgenic mice contained five copies of the transgene (Figure 2A). This analysis also revealed that the intensity of the neo decreased to approximately20% in U6-Fgfr2;EIIa-Cre embryos compared with the embryos without Cre (Figure 2A). The similar decrease of neo intensity was also revealed by genomic PCR analysis using primers against the neo (Figure 2B). To confirm that this reduction is caused by neo deletion, we performed PCR using primers flanking the ploxPneo. Our analysis detected Cre-mediated deletion (del) product in DNA isolated from U6-Fgfr2;EIIa-Cre embryos, but not in DNA isolated from embryos with other genotypes (Figure 2B). Then, we performed northern blot analysis using RNAs extracted from U6-Fgfr2;EIIa-Cre, wild type and U6-ploxPneo-Fgfr2 whole embryos. Our analysis detected a strong band of predicted size of 86 nt (63 bases for the two RNAi oligos and hairpin sequences and 23 bases from transcription initiation site to the beginning of the first oligo) in U6-Fgfr2;EIIa-Cre, but not in wild-type and U6-ploxPneo-Fgfr2 embryos (Figure 2C). These data provide in vivo evidence that the presence of the neo gene efficiently silenced the U6 promoter and its deletion restored the promoter activity.
###end p 28
###begin p 29
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 80 93 80 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2 in vivo</italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 200 217 200 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 280 297 280 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 302 310 302 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 362 371 362 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 455 463 455 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2</italic>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 535 544 535 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 646 663 646 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 703 712 703 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 800 817 800 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
Next, we determined if the expression of Fgfr2 RNAi could efficiently knockdown Fgfr2 in vivo using RT-PCR. Our data revealed a dramatic (>95%) down-regulation of Fgfr2 mRNA levels in all three E12.5 U6-Fgfr2;EIIa-Cre embryos examined, while no obvious alteration was observed in U6-ploxPneo-Fgfr2 and EIIa-Cre embryos compared with their wild-type littermates (Figure 3A). Fgf receptors exist as a gene family of four members. Our analysis revealed that U6-Fgfr2 RNAi-mediated suppression is specific to Fgfr2, but not other members (Figure 3A). Finally, our real-time PCR analysis confirmed dramatic down-regulation of Fgfr2 transcripts in the U6-Fgfr2;EIIa-Cre, but not in any other control embryos (Figure 3B). These observations provide a molecular basis for the observed embryonic lethality of U6-Fgfr2;EIIa-Cre embryos.
###end p 29
###begin title 30
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
Limb distal mesenchyme-specific knockdown of Fgfr2 results in abnormal digit formation
###end title 30
###begin p 31
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 329 346 329 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 357 364 357 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-Cre</italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 597 613 597 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;AP2-Cre</italic>
###xml 625 632 625 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 650 667 650 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 672 679 672 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-Cre</italic>
###xml 704 720 704 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;AP2-Cre</italic>
###xml 827 836 827 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 853 862 853 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1098 1107 1098 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 1138 1147 1138 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4D</xref>
###xml 1224 1233 1224 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4E</xref>
###xml 1299 1308 1299 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4F</xref>
###xml 1415 1430 1415 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4E and F</xref>
###xml 1478 1495 1478 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 1500 1507 1500 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-Cre</italic>
###xml 1526 1541 1526 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C and D</xref>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 365 380 <span type="species:ncbi:10090">transgenic mice</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
###xml 1666 1671 <span type="species:ncbi:10090">mouse</span>
Thus, we have created a Cre-mediated conditional Fgfr2 mutant strain using the RNAi technology. This strain of mice should be a useful tool for studying functions of Fgfr2 in the development and formation of multiple organs/tissues. To demonstrate this in principle, we performed limb-specific knockdown of Fgfr2 by crossing the U6-ploxPneo-Fgfr2 mice with AP2-Cre transgenic mice, which express Cre in the distal mesenchyme [also called progress zone (27)] right after limb bud initiation (25). After crossing with the two strains, we observed a normal distribution of double transgenic animals (U6-Fgfr2;AP2-Cre) at birth (Table 1, crosses between U6-ploxPneo-Fgfr2 and AP2-Cre mice). However, all the U6-Fgfr2;AP2-Cre animals exhibited limb abnormalities characterized by the reduced number of digits in both the forelimbs (Figure 4A) and hindlimbs (Figure 4B). Alizarin red- and alcian blue-stained whole-mount skeleton imaging revealed that all mutant forelimbs only had two relatively normal digits (digits 4 and 5), while the anterior digits were either missing or developmentally retarded (Figure 4C) in comparison with controls (Figure 4D). On the other hand, all the mutant hindlimbs did not have the third digit (Figure 4E, arrow), while other digits present, however, appeared abnormal (Figure 4F). Furthermore, mutant hindlimbs showed delayed ossification of tarsal bones and distortion in the ankles (Figure 4E and F). In contrast, all control animals (wild type, U6-ploxPneo-Fgfr2 and AP2-Cre) appeared normal (Figure 4C and D). Collectively, these results demonstrate that RNAi can be used to achieve spatial and temporal knockdown of transcripts in mouse.
###end p 31
###begin title 32
DISCUSSION
###end title 32
###begin p 33
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 243 245 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 413 415 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 498 505 486 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 566 568 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 604 612 592 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2</italic>
###xml 647 652 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 701 706 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 825 830 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 1003 1005 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 1012 1029 1000 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 1398 1403 1386 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 621 626 <span type="species:ncbi:10090">mouse</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
###xml 1164 1179 <span type="species:ncbi:10090">transgenic mice</span>
The 3 x 109 base sequence of mouse genome encodes at least 30 000 genes. Despite great efforts having been directed at deciphering functions of these genes by gene targeting, published knockouts represent only approximately10% of mouse genes (28). One of the obvious rate limiting factors is the generation of mutant mice, especially those carrying conditional mutations, which requires multi-step modifications (29). In this paper, we have described a method that can be used for conditional RNAi in vivo on endogenous genes, using the widely used Cre-LoxP system (15). We showed that the expression of U6-Fgfr2 RNAi in mouse germline suppressed Fgfr2 expression with high efficiency, as only <5% of Fgfr2 transcripts were detected compared with those of controls. We have also performed progress-zone-specific knockdown of Fgfr2 and demonstrated, in principle, that our strategy can be applied for tissue-specific targeted gene suppression. Given the critical roles of Fgfr2 in mammalian development (17), the U6-ploxPneo-Fgfr2 mice should be useful in assessing functions of this gene in multiple organs/tissues. We are in the process to cross this strain with transgenic mice that express Cre in a number of other tissues. Because the ratio of RNAi to targeted mRNA varies from one cell type to another, the efficiency of RNAi knockdown may change. We will carefully evaluate the efficiency of Fgfr2 knockdown in different tissues.
###end p 33
###begin p 34
###xml 229 246 229 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
Because our approach does not require constructing sophisticated gene-targeting vectors and ES cell manipulation, it is relatively fast to generate mutant mice carrying RNAi construct. In this study, we were able to generate the U6-ploxPneo-Fgfr2 mice in 3 months, a significant gain of time compared with homologous recombination procedures for the conditional gene knockouts (12-24 months). Moreover, because RNAi acts dominantly, only one allele of transgene is needed to suppress the endogenous genes, and it reduces the time needed for breeding together two mutant alleles required by conditional knockout of genes with recessive nature. This advantage becomes more obvious when genetic interaction of two or more genes is studied (30,31). Thus, compared with the gene targeting technique, our approach is both fast and simple, and therefore should be widely accessible.
###end p 34
###begin p 35
###xml 17 34 17 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 151 168 151 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 190 198 190 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 199 214 <span type="species:ncbi:10090">transgenic mice</span>
In our approach, U6-ploxPneo-Fgfr2 construct was introduced through pronuclear injection to obtain mutant mice. Although our crosses between all three U6-ploxPneo-Fgfr2 founder strains with EIIa-Cre transgenic mice resulted in similar embryonic lethality, the expression of transgenes, in theory, should subject to position effects. This is primarily caused by random integration of transgenes into different chromosomal sites that differentially regulate gene expression (32). Thus, the activity of U6 promoter may vary at different integration sites. Apparently, position independent and high levels of gene expression are essential for the success of our approach. It is reported recently that position effect can be minimized or overcome by using an insulator (33). This is a promising strategy that should be tested in the next generation of the RNAi constructs.
###end p 35
###begin p 36
###xml 18 35 18 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 162 179 162 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 184 192 184 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 592 600 592 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ploxPneo</italic>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 875 883 875 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ploxPneo</italic>
###xml 1206 1208 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1209 1211 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 2261 2269 2249 2257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 2320 2337 2308 2325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 2392 2400 2380 2388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 2508 2525 2496 2513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 2629 2646 2617 2634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 1727 1742 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1774 1789 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2027 2042 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2116 2131 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2227 2231 <span type="species:ncbi:10090">mice</span>
###xml 2270 2274 <span type="species:ncbi:10090">mice</span>
###xml 2338 2353 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2401 2405 <span type="species:ncbi:10090">mice</span>
###xml 2526 2530 <span type="species:ncbi:10090">mice</span>
###xml 2647 2651 <span type="species:ncbi:10090">mice</span>
We found that the U6-Fgfr2;EIIa-Cre animals died at different stages of embryonic development and two mutant mice survived to adulthood (Table 1, crosses between U6-ploxPneo-Fgfr2 and EIIa-Cre mice). Because all these mice were derived from a single transgenic founder line, this variation was not due to the position effects on the transgene. Instead, it could be due to the fact that each animal contained varying degree of Fgfr2 knockdown level, with most severe knockdown leading to earlier lethality. One of the factors that may affect the efficiency of Fgfr2 knockdown is the extent of ploxPneo deletion. Based on our experience on conditional knockout of a number of genes, Cre-mediated deletion of floxed sequences is in a range of 60-90% and never reaches 100% even in the most efficient case (31,34). Our real-time PCR analysis indicated that the efficiency of the ploxPneo deletion by EIIa-Cre is approximately80%, which is comparable with efficiencies of most conditional knockouts. Another factor that may affect Cre efficiency is the copy number of loxP. It was shown previously that EIIa-Cre could cause incomplete deletion of DNA sequences containing three loxP sites and create mosaicism (35,36). Thus, efficiency of Cre may be further reduced in situations when many copies of transgene were cumulated at one locus. In this case, weak Cre activity may result in a variable number of active transgene while in case of strong Cre, only one active transgene will be left. This could result in an additional level of phenotypic variation. One way to avoid high copy number of the transgene is to reduce concentration of DNA for pronuclear injection. Furthermore, phenotypic variation could also occur if the RNAi transgenic mice used for the crossing with Cre-transgenic mice still carried more than one transgene integration that had not yet segregated from each other. Although the integration of transgene into multiple loci is uncommon, it needs to take into account. One way to overcome this is to breed the transgenic mice with wild-type for a number of generations before crossing them with Cre transgenic mice. However, this may be both time and labor consuming. In this study, instead of using wild-type mice, we directly crossed F1 with EIIa-Cre mice, as this cross should generate one-fourth of U6-ploxPneo-Fgfr2 transgenic mice (F2), which were further crossed with EIIa-Cre mice to generate F3, then F4 and so on. At the same time, these crosses should also generate one-fourth of U6-Fgfr2;EIIa-Cre mice at each generation that can be used for phenotypic analysis. During the course of this work, some U6-Fgfr2;EIIa-Cre mice have reached more than seven generations and they still showed same phenotype compared with earlier generations.
###end p 36
###begin p 37
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
On the other hand, phenotype variation is often observed in mice generated by gene targeting, suggesting that it is an intrinsic feature associated with the loss of function mutation, perhaps due to a difference response of each individual to the mutation. Actually, this could be beneficial in some circumstances where variable phenotypes associated with some knockouts may reveal new and unexpected information. Thus, scientists intentionally generate hypomorphic alleles using sophisticated targeting modifications (37). This is a challenge for RNAi after minimizing the undesired position effects; however, it may be achieved in two ways: one is the actual copy number of the RNAi transgene (i.e. breeding of heterozygote to homozygote), and the other is using a suboptimal shRNA vector, as varying efficiency always occurs in culture cells when different sequences of the same gene are used.
###end p 37
###begin p 38
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 436 441 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 464 471 464 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
During the course of this study, two recent investigations showed that lentivirus-based RNAi systems could be used to generate transgenic animals with Cre-loxP mediated gene knockdown (38,39). While it is not possible to have a direct comparison between different approaches, our work is the first demonstration that the plasmid-based RNAi, with its simplicity in construction, can be used to specifically knockdown an endogenous gene, Fgfr2, with high efficiency in vivo. Because all the techniques using RNAi to suppress endogenous genes are still in their early developing stages, our method should provide an additional choice for this scientific field.
###end p 38
###begin p 39
The authors thank H. Lu for pronuclear injection, Dr S. Lee and members of Deng laboratory for critical discussion and comments of the manuscript. Funding to pay the Open Access publication charges for this article was provided by National Institutes of Health, USA.
###end p 39
###begin p 40
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 40
###begin title 41
REFERENCES
###end title 41
###begin article-title 42
The RNAi revolution
###end article-title 42
###begin article-title 43
RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells
###end article-title 43
###begin article-title 44
Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system
###end article-title 44
###begin article-title 45
RNA interference is mediated by 21- and 22-nucleotide RNAs
###end article-title 45
###begin article-title 46
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
###end article-title 46
###begin article-title 47
Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin
###end article-title 47
###begin article-title 48
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Inducible shRNA expression for application in a prostate cancer mouse model
###end article-title 48
###begin article-title 49
Inducible, reversible, and stable RNA interference in mammalian cells
###end article-title 49
###begin article-title 50
Establishment of conditional vectors for hairpin siRNA knockdowns
###end article-title 50
###begin article-title 51
###xml 98 102 <span type="species:ncbi:10090">mice</span>
The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice
###end article-title 51
###begin article-title 52
Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase
###end article-title 52
###begin article-title 53
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice
###end article-title 53
###begin article-title 54
Conditional gene knockout using cre recombinase
###end article-title 54
###begin article-title 55
Altering the genome by homologous recombination
###end article-title 55
###begin article-title 56
Cre recombinase: the universal reagent for genome tailoring
###end article-title 56
###begin article-title 57
Fibroblast growth factors
###end article-title 57
###begin article-title 58
Roles of FGF receptors in mammalian development and congenital diseases
###end article-title 58
###begin article-title 59
Fibroblast growth factor receptors from liver vary in three structural domains
###end article-title 59
###begin article-title 60
Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities
###end article-title 60
###begin article-title 61
###xml 47 52 <span type="species:ncbi:9606">human</span>
Fibroblast-growth-factor receptor mutations in human skeletal disorders
###end article-title 61
###begin article-title 62
Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development
###end article-title 62
###begin article-title 63
Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction
###end article-title 63
###begin article-title 64
Fibroblast growth factor receptor 2 (Fgfr2) plays an important role in eyelid and skin formation and patterning
###end article-title 64
###begin article-title 65
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage
###end article-title 65
###begin article-title 66
Frontonasal process-specific disruption of AP-2alpha results in postnatal midfacial hypoplasia, vascular anomalies, and nasal cavity defects
###end article-title 66
###begin article-title 67
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S
###end article-title 67
###begin article-title 68
###xml 26 31 <span type="species:ncbi:9031">chick</span>
Positional information in chick limb morphogenesis
###end article-title 68
###begin article-title 69
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
The knockout mouse project
###end article-title 69
###begin article-title 70
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Generation and analysis of Brca1 conditional knockout mice
###end article-title 70
###begin article-title 71
###xml 104 110 <span type="species:ncbi:10090">murine</span>
Fibroblast growth factor receptor-3 and receptor-4 function cooperatively to direct alveogenesis in the murine lung
###end article-title 71
###begin article-title 72
Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
###end article-title 72
###begin article-title 73
Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals
###end article-title 73
###begin article-title 74
###xml 31 37 <span type="species:ncbi:10090">murine</span>
###xml 63 78 <span type="species:ncbi:10090">transgenic mice</span>
###xml 194 201 <span type="species:ncbi:9031">chicken</span>
Variegated expression from the murine band 3 (AE1) promoter in transgenic mice is associated with mRNA transcript initiation at upstream start sites and can be suppressed by the addition of the chicken beta-globin 5' HS4 insulator element
###end article-title 74
###begin article-title 75
###xml 117 121 <span type="species:ncbi:10090">mice</span>
Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice
###end article-title 75
###begin article-title 76
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Direct removal in the mouse of a floxed neo gene from a three-loxP conditional knockout allele by two novel approaches
###end article-title 76
###begin article-title 77
Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene
###end article-title 77
###begin article-title 78
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Tumor formation in Brca1 conditional mutant mice
###end article-title 78
###begin article-title 79
Cre-lox-regulated conditional RNA interference from transgenes
###end article-title 79
###begin article-title 80
Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown
###end article-title 80
###begin title 81
Figures and Tables
###end title 81
###begin p 82
###xml 14 16 14 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6</italic>
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 56 57 56 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 72 74 72 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6</italic>
###xml 75 89 75 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ploxPneo-Fgfr2</italic>
###xml 129 137 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ploxPneo</italic>
###xml 140 141 140 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 147 164 147 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 226 227 226 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 232 233 232 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 237 238 237 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 243 244 243 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 317 334 317 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 341 349 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 363 380 363 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
Expression of U6-Fgfr2 results in embryonic lethality. (A) Structure of U6-ploxPneo-Fgfr2 transgene before and after deletion of ploxPneo. (B) P19 U6-Fgfr2;EIIa-Cre and control mice. Abnormal limbs (arrows) were magnified in (C and D). (E and F) E11.5 (E) and E13.5 (F) mutant and control embryos. Wt, wild type; U6, U6-ploxPneo-Fgfr2; Cre, EIIa-Cre; and U6;Cre, U6-Fgfr2;EIIa-Cre.
###end p 82
###begin p 83
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 38 55 38 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 132 149 132 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 224 232 224 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sirt6+/&#8722;</italic>
###xml 237 245 237 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr1&#8722;/&#8722;</italic>
###xml 303 306 303 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr1</italic>
###xml 388 389 388 389 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 405 408 405 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 456 464 456 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ploxPneo</italic>
###xml 466 469 466 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 501 504 501 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 516 519 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 594 595 594 595 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 633 641 633 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2</italic>
###xml 673 690 673 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
Cre-mediated deletion of the neo from U6-ploxPneo-Fgfr2 transgene allows expression of Fgfr2 RNAi. (A) Assessment of copy number of U6-ploxPneo-Fgfr2 transgene by real-time PCR using primers for neo gene. DNA extracted from Sirt6+/- and Fgfr1-/- ES cells are used as controls for 1 copy and 2 copies of neo gene, respectively. Primers for Fgfr1 genomic DNA are used as analysis control. (B) Assessment of neo gene deletion by genomic PCR using primers for ploxPneo (neo) and primers that flanking the neo. PCR using neo primers is stopped at 25 cycles and all others are stopped at 30 cycles. (C) Northern blot analysis showing that U6-Fgfr2 transgene is only expressed in U6-Fgfr2;EIIa-Cre mice. Equal RNA loading was assessed by ethidium bromide staining of the upper portion of the gel (lower). All samples, except for those from ES cells, are from E12.5 embryos.
###end p 83
###begin p 84
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr1-4</italic>
###xml 33 34 33 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr1-4</italic>
###xml 134 151 134 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2</italic>
###xml 158 166 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 180 197 180 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-Fgfr2;EIIa-Cre</italic>
###xml 254 255 254 255 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
Analysis of Fgfr1-4 expression. (A) RT-PCR analysis of Fgfr1-4 expression in E12.5 embryos of different genotypes. Wt, wild type; U6, U6-ploxPneo-Fgfr2; Cre, EIIa-Cre; and U6;Cre, U6-Fgfr2;EIIa-Cre. The first row is a longer exposure of the second row. (B) Real-time PCR analysis of Fgfr2 mRNA levels. Three embryos for each genotype were shown. The three mutant embryos used here were less affected and had similar size compared with the littermate controls. The experiments were repeated at least three times and similar data were obtained on each time.
###end p 84
###begin p 85
###xml 49 51 49 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6</italic>
###xml 52 65 52 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2;Ap-2Cre</italic>
###xml 73 74 73 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 79 80 79 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 85 87 85 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6</italic>
###xml 88 101 88 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2;Ap-2Cre</italic>
###xml 148 149 148 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 150 151 150 151 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 191 193 191 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6</italic>
###xml 194 207 194 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2;Ap-2Cre</italic>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Abnormal digit formation and limb development in U6-Fgfr2;Ap-2Cre mice. (A and B) P7 U6-Fgfr2;Ap-2Cre and control forelimbs (A) and hindlimbs (B). (C-F) Alizarin red- and alcian-blue stained U6-Fgfr2;Ap-2Cre (C and E) and control (D and F) limbs. (C and D) were forelimbs, and (E and F) were hindlimbs. Arrow in (E) points to the third finger, which is truncated in all mutant limbs. Arrow in (F) points to calcified tarsal bones, which have not developed in mutant bones (E). Note, the tibia and fibula of mutant hindlimbs (E) were out of focus because of a distortion in the ankle. Ra, radius; Ul, ulna; Ti, tibia; Fi, fibula.
###end p 85
###begin p 86
###xml 43 65 43 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U6-ploxPneo-Fgfr2 mice</italic>
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIa-Cre</italic>
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2-Cre</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 100 115 <span type="species:ncbi:10090">transgenic mice</span>
Offspring and genotypes of crosses between U6-ploxPneo-Fgfr2 mice (Line A) with EIIa-Cre or AP2-Cre transgenic mice
###end p 86
###begin p 87
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aSmall size and limb abnormalities.
###end p 87
###begin p 88
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bAll displayed limb defects.
###end p 88

